Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells

Abstract

The cyclin-dependent kinase inhibitor p27Kip1 has been implicated as a drug resistance factor in tumor cells grown as spheroids or confluent monolayers. Here, we show that p27Kip1 overexpression also induces resistance to drug-induced apoptosis and cytotoxicity in human leukemic cells growing in suspension. The anti-apoptotic effect of p27Kip1 is not restricted to DNA-damaging agents but extends to the tubulin poison vinblastin, agonistic anti-Fas antibodies and macromolecule synthesis inhibitors. To further identify at which level this protein interferes with the cell death pathway, we investigated its influence on caspase activation and mitochondrial changes. Exposure of mock-transfected U937 cells to 50 μM etoposide activates procaspase-3 and the long isoform of procaspase-2 and induces mitochondrial potential decrease and cytochrome c release from mitochondria to the cytosol. All these events are prevented by p27Kip1 overexpression. p27Kip1 does not modulate Bcl-2, Bcl-XL, Mcl-1 and Bax protein level in leukemic cells but suppresses Mcl-1 expression decrease observed in mock-transfected U937 cells undergoing etoposide-induced cell death. We conclude that p27Kip1 prevents cell death upstream of the final pathway common to many apoptotic stimuli that involves cytochrome c release from mitochondria and activation of downstream caspases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bertrand R, Kohn KW, Solary E and Pommier Y. . 1995 Drug Dev. Res. 34: 138–144.

    Article  CAS  Google Scholar 

  • Boudreau N, Sympson CJ, Werb Z and Bissell MJ. . 1995 Science 267: 891–893.

    Article  CAS  Google Scholar 

  • Cardone MH, Salvesen GS, Widmann C, Johnson G and Frisch SM. . 1997 Cell 90: 315–323.

    Article  CAS  Google Scholar 

  • Cohen GM. . 1997 J. Biochem. 326: 1–16.

  • Craig C, Wersto R, Kim M, Ohri E, Li Z, Katayose D, Lee SJ, Trepel J, Cowan K and Seth P. . 1997 Oncogene 14: 2283–2289.

    Article  CAS  Google Scholar 

  • Dimanche-Boitrel MT, Micheau O, Hamman A, Haugg M, Eymin B, Chauffert B and Solary E. . 1998 Int. J. Cancer in press.

  • Droin N, Dubrez L, Eymin B, Renvoizé C, Bréard J, Dimanche-Boitrel MT and Solary E. . 1998 Oncogene in press.

  • Duan H and Dixit VM. . 1997 Nature 385: 86–89.

    Article  CAS  Google Scholar 

  • Dubrez L, Savoy I, Hamman A and Solary E. . 1996 EMBO J. 15: 5504–5512.

  • Duttaroy A, Qian JF, Smith JS and Wang E. . 1997 J. Cell. Biochem. 64: 434–446.

    Article  CAS  Google Scholar 

  • Evan GI, Brown L, Whyte M and Harrington E. . 1995 Curr. Opin. Cell Biol. 7: 825–834.

  • Eymin B, Solary E, Chevillard S, Dubrez L, Goldwasser F, Duchamp O, Genne P, Leteurtre F and Pommier, Y. . 1995 Int. J. Cancer 63: 268–275.

    Article  CAS  Google Scholar 

  • Eymin B, Dubrez L, Allouche M and Solary E. . 1997 Cancer Res. 57: 686–695.

  • Gorospe M, Wang X, Guyton KZ and Holbrook JN. . 1996 Mol. Cell. Biol. 16: 6654–6660.

    Article  CAS  Google Scholar 

  • Han ZY, Hendrickson EA, Bremner TA and Wyche JH. . 1997 J. Biol. Chem. 272: 13432–13436.

    Article  CAS  Google Scholar 

  • Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K and Sasada M. . 1998 J. Exp. Med. 4: 587–600.

  • Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan KH and Seth P. . 1997 Cancer Res. 57: 5441–5445.

  • Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD. . 1997 Science 275: 1132–1134.

  • Levkau B, Koyama H, Raines EW, Clurman BE, Herren B, Orht K, Roberts JM and Ross R. . 1998 Molec. Cell 1: 553–563.

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X. . 1997 Cell 91: 479–488.

    Article  CAS  Google Scholar 

  • Liu X, Kim CN, Yang J, Jemmerson R and Wang X. . 1996 Cell 86: 147–157.

    Article  CAS  Google Scholar 

  • Lu Y, Yamagishi N, Yagi T and Takebe H. . 1998 Oncogene 16: 705–712.

    Article  CAS  Google Scholar 

  • Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T, Yu VL and Miller DK. . 1995 Nature 376: 37–45.

    Article  CAS  Google Scholar 

  • Pan ZQ, Reardon JT, Li L, Floresrozas H, Legerski R, Sancar A and Hurwitz J. . 1995 J. Biol. Chem. 270: 22008–22016.

    Article  CAS  Google Scholar 

  • Reed JC. . 1997 Cell 91: 559.

    Article  CAS  Google Scholar 

  • Rossé T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B and Borner C. . 1998 Nature 391: 496–499.

    Article  Google Scholar 

  • Salvesen GS and Dixit VM. . 1997 Cell 91: 443–446.

    Article  CAS  Google Scholar 

  • Sherr JC. . 1996 Science 274: 1672–1677.

    Article  CAS  Google Scholar 

  • Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW and Greenberg AH. . 1994 Science 263: 1143–1145.

    Article  CAS  Google Scholar 

  • Solary E, Bertrand R, Kohn KW and Pommier Y. . 1993 Blood 81: 1359–1368.

  • Solary E, Eymin B, Droin N and Haugg M. . 1998 Cell Biol. Tox. 14: 121–132.

  • St Croix B, Florenes VA, Rak JW, Flanagan M, Bhattacharaya N, Slingerland JM and Kerbel RS. . 1996 Nature Med. 2: 1204–1210.

  • Susin SA, Zamzami N, Castedo T, Hirsch P, Marchetti A, Macho E, Daugas E, Geusken M and Kroemer G. . 1996 J. Exp. Med. 184: 1331–1342.

  • Susin SA, Zamzani N, Castedo M, Daugas E, Wang H, Geley S, Fassy F, Reed JC and Kroemer G. . 1997 J. Exp. Med. 186: 25–37.

  • VanderHeiden MG, Chandel NS, Williamson EK, Schumacker PT and Thompson CB. . 1997 Cell 91: 627–637.

    Article  CAS  Google Scholar 

  • Waldman T, Lengauer C, Kinzler KW and Vogelstein B. . 1996 Nature 381: 713–716.

    Article  CAS  Google Scholar 

  • Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, Vogelstein B and Williams J. . 1997 Nature Med. 3: 1034–1036.

  • Wang XT, Gorospe M, Huang Y and Holbrook NJ. . 1997 Oncogene 15: 2991–2997.

    Article  CAS  Google Scholar 

  • Yan YM, Lee MH, Massague J and Barbacid M. . 1997 Genes & Dev. 11: 973–983.

  • Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X. . 1997 Science 275: 1129–1131.

    Article  CAS  Google Scholar 

  • Zhang W, Kornblau SM, Kobayashi T, Gambel A, Claxton D and Deisseroth AB. . 1995 Clin. Cancer Res. 1: 1051–1057.

Download references

Acknowledgements

This work was supported by grants from the Burgundy, Saóne et Loire & Yonne Comitees of the Ligue Nationale Contre le Cancer, from the Association pour la Recherche Contre le Cancer (# 4075) and the Conseil Régional de Bourgogne. Béatrice Eymin was supported by the CHU Le Bocage, Dijon, France.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eymin, B., Haugg, M., Droin, N. et al. p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells. Oncogene 18, 1411–1418 (1999). https://doi.org/10.1038/sj.onc.1202437

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202437

Keywords

This article is cited by

Search

Quick links